MET and B-cell chronic lymphocytic leukemia: Genetic knockdown of the c-MET gene via lentivirus-delivered shRNA, as well as pharmacological inhibition of HGF/c-MET pathway using the small-molecule inhibitor capmatinib, attenuated these pro-survival signals and effectively induced apoptosis in CLL cells.